Home » Nascent Nymox Pharmaceutical Reports Quarterly Loss
Nascent Nymox Pharmaceutical Reports Quarterly Loss
Nymox Pharmaceutical reported a second quarter net loss of $1.7 million, or 5 cents a share, as its lead product advances into late-stage development.
New Jersey Star-Ledger
New Jersey Star-Ledger
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May